Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,717,957
  • Shares Outstanding, K 114,760
  • Annual Sales, $ 46,550 K
  • Annual Income, $ -75,240 K
  • 60-Month Beta 1.37
  • Price/Sales 36.71
  • Price/Cash Flow N/A
  • Price/Book 24.33
Trade DVAX with:

Options Overview

Details
  • Implied Volatility 101.31%
  • Historical Volatility 110.48%
  • IV Percentile 57%
  • IV Rank 24.33%
  • IV High 213.51% on 02/01/21
  • IV Low 65.24% on 06/16/21
  • Put/Call Vol Ratio 0.13
  • Today's Volume 3,121
  • Volume Avg (30-Day) 6,456
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 52,388
  • Open Int (30-Day) 50,142

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.05
  • Number of Estimates 3
  • High Estimate 0.29
  • Low Estimate -0.18
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +133.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.31 +21.61%
on 08/23/21
20.40 -26.62%
on 09/01/21
+2.93 (+24.34%)
since 08/20/21
3-Month
8.80 +70.11%
on 06/22/21
20.40 -26.62%
on 09/01/21
+6.04 (+67.64%)
since 06/18/21
52-Week
3.58 +318.16%
on 10/29/20
20.40 -26.62%
on 09/01/21
+9.54 (+175.69%)
since 09/18/20

Most Recent Stories

More News
First Week of November 19th Options Trading For Dynavax Technologies (DVAX)

Investors in Dynavax Technologies Corp saw new options become available this week, for the November 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX...

DVAX : 14.97 (+0.54%)
Stocks Finally Have a Solid Session in September

Stocks Finally Have a Solid Session in September

WAL : 95.89 (-2.51%)
DVAX : 14.97 (+0.54%)
EXAS : 105.15 (-2.77%)
Spirit AeroSystems, Hess rise; Dynavax, TransUnion fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

TRU : 115.59 (-0.42%)
CP.TO : 83.95 (-2.08%)
DVAX : 14.97 (+0.54%)
HES : 67.60 (-5.24%)
DXCM : 557.76 (-0.96%)
RGNX : 43.58 (-3.24%)
ITMR : 30.20 (-0.33%)
KSU : 271.71 (-2.07%)
Pre-Market Brief: U.S. Stocks Set to Open Higher on Tech and Energy Stocks

Morning Markets Dec S&P 500 futures this morning are up +0.57% as they recover more than half of Friday’s decline. Strength in energy and technology stocks in pre-market trading is supportive for the...

AAPL : 142.94 (-2.14%)
PINS : 52.51 (-4.13%)
VIAC : 38.86 (-2.83%)
MGM : 41.28 (-0.63%)
VRT : 23.86 (+0.55%)
ABNB : 161.64 (-2.97%)
BABA : 151.49 (-5.35%)
NTES : 80.06 (-3.40%)
PDD : 94.18 (-6.50%)
BIDU : 154.50 (-4.75%)
DVAX : 14.97 (+0.54%)
Dynavax Provides Update on its COVID-19 Collaboration with Valneva

/PRNewswire/ --  (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that has received a termination notice from the United Kingdom Government...

DVAX : 14.97 (+0.54%)
Analysts Make the Case for Small-Cap Biotech Stocks This Fall (INMB, DVAX, SAVA, ICPT, IMGN, ATRX)

IBB : 169.91 (-2.13%)
MRNA : 423.33 (-1.56%)
INMB : 17.19 (-6.27%)
ATRX : 0.1600 (-11.11%)
SAVA : 48.26 (-0.52%)
DVAX : 14.97 (+0.54%)
ICPT : 15.18 (-4.71%)
IMGN : 5.73 (-1.21%)
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ --  (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 224,000 shares of Dynavax common stock as inducements to 8 newly-hired employees...

DVAX : 14.97 (+0.54%)
Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine

Dynavax (DVAX) stock gains as partner Medigen announces launch of its COVID-19 vaccine MVC-COV1901 adjuvanted with CpG 1018 of the former.

DVAX : 14.97 (+0.54%)
PFE : 44.20 (+0.71%)
RGEN : 306.05 (-0.28%)
BNTX : 339.01 (-5.62%)
NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High

NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High

AI : 47.06 (-6.11%)
DKS : 131.91 (-1.07%)
CAR : 94.93 (-0.41%)
TXT : 68.60 (+0.20%)
CBRE : 94.53 (-1.31%)
CB : 177.89 (-1.47%)
IPG : 36.22 (-2.08%)
SKX : 44.83 (-0.86%)
TPX : 47.63 (+0.11%)
VRT : 23.86 (+0.55%)
DVAX : 14.97 (+0.54%)
EDIT : 58.20 (-7.91%)
PFE : 44.20 (+0.71%)
BBY : 106.67 (-2.69%)
JWN : 27.78 (-1.21%)
URBN : 32.15 (-1.14%)
AAP : 203.71 (-1.02%)
TOL : 60.69 (-3.50%)
Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine MVC-COV1901 Adjuvanted with Dynavax's CpG 1018 Adjuvant

and , /PRNewswire/ --  (MVC) (TPEx: 6547.TWO), a biopharmaceutical company focusing on the development and production of vaccines and biologics, and (Nasdaq: DVAX), a biopharmaceutical company focused...

DVAX : 14.97 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

3rd Resistance Point 16.21
2nd Resistance Point 15.69
1st Resistance Point 15.33
Last Price 14.97
1st Support Level 14.45
2nd Support Level 13.93
3rd Support Level 13.57

See More

52-Week High 20.40
Last Price 14.97
Fibonacci 61.8% 13.97
Fibonacci 50% 11.99
Fibonacci 38.2% 10.01
52-Week Low 3.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar